S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4753 Reports
🤖 AI Analyzed
Recent
📄 Page 99 of 397
CaliberCos Inc.
10-K March 26, 2026

Key Highlights

  • Manages $2.6 billion in diverse real estate assets including hotels and industri...
  • Pioneering a digital asset treasury by integrating Chainlink for fractional real...
  • Potential for $104 million in future performance fees from the current project p...
Read Analysis
🤖 AI Generated
CollPlant Biotechnologies Ltd
20-F March 26, 2026

Key Highlights

  • Proprietary rhCollagen technology derived from tobacco plants avoids animal-deri...
  • Strategic partnership with AbbVie for regenerative breast implants with a deal v...
  • Focus on high-growth medical aesthetics and 3D bioprinting bio-inks.
Read Analysis
🤖 AI Generated
AB Private Credit Investors Corp
10-K March 26, 2026

Key Highlights

  • Stable 7.2% dividend yield backed by a $1.86 billion loan portfolio.
  • Senior secured lender status provides priority repayment protection.
  • Active management with a strict 4% deal approval rate.
Read Analysis
🤖 AI Generated
MetaVia Inc.
10-K March 26, 2026

Key Highlights

  • Phase 2a study for vanoglipel demonstrated significant reduction in liver fat an...
  • Phase 1 results for DA-1726 showed a 9.1% body weight loss over 56 days with a f...
  • Outsourced operational model keeps research costs low while focusing on high-pot...
Read Analysis
🤖 AI Generated
Ferroglobe PLC
20-F March 26, 2026

Key Highlights

  • Successfully reduced debt burden by $350 million in 2024.
  • Strategic pivot toward cost-cutting initiatives totaling $60 million.
  • Essential supplier for critical industries including solar, steel, and aluminum.
Read Analysis
🤖 AI Generated
Insight Molecular Diagnostics Inc.
10-K March 26, 2026

Key Highlights

  • Strategic pivot from high-cost lab services to a scalable diagnostic kit model.
  • Rebranding of core test portfolio under the GraftAssure name to drive hospital a...
  • Targeting a 40% increase in test volume for 2025 alongside a 30% reduction in op...
Read Analysis
🤖 AI Generated
Nouveau Monde Graphite Inc.
40-F March 26, 2026

Key Highlights

  • Secured $375 million USD in strategic funding from General Motors, Panasonic Ene...
  • Vertically integrated supply chain model controlling graphite from mine to batte...
  • Strong off-take agreements with major industry partners validate technology and ...
Read Analysis
🤖 AI Generated
ACTUATE THERAPEUTICS, INC.
10-K March 26, 2026

Key Highlights

  • Clinical-stage biotech focused on the single drug candidate elraglusib.
  • Successfully completed IPO and follow-on offerings to fund operations through la...
  • Upcoming 2026 regulatory meetings to determine the path for Phase 3 clinical tri...
Read Analysis
🤖 AI Generated
enVVeno Medical Corp
10-K March 26, 2026

Key Highlights

  • Development of the enVVe System, a minimally invasive transcatheter device for c...
  • Strategic pivot from the failed VenoValve project to a next-generation catheter-...
  • Planned 2026 pivotal trial targeting 150-200 patients to prove safety and effica...
Read Analysis
🤖 AI Generated
Morgan Stanley Capital I Trust 2016-UBS9
10-K March 26, 2026

Key Highlights

  • Successful repayment of major loans including 525 Seventh Avenue and Ellenton Pr...
  • Significant reduction in total outstanding balance from $1.05 billion to approxi...
  • Remaining properties currently meet required debt service coverage ratios.
Read Analysis
🤖 AI Generated
Duke Energy Florida Project Finance, LLC
10-K March 26, 2026

Key Highlights

  • Bankruptcy-remote structure ensures separation from parent company risks
  • Stable cash flow derived from state-mandated charges on Florida ratepayers
  • Strong financial backing supported by a $2.0 billion Brookfield investment in th...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage